CNL-22-096, to Request for License Amendment Regarding Application of Advanced Framatome Methodologies, and Adoption of TSTF-564 Revision 2 for Browns Ferry Nuclear Plant Units 1, 2, and 3, in Support of Atrium 11 Fuel Use at Browns Ferry (TS-535)

From kanterella
Jump to navigation Jump to search

to Request for License Amendment Regarding Application of Advanced Framatome Methodologies, and Adoption of TSTF-564 Revision 2 for Browns Ferry Nuclear Plant Units 1, 2, and 3, in Support of Atrium 11 Fuel Use at Browns Ferry (TS-535)
ML22272A054
Person / Time
Site: Browns Ferry  Tennessee Valley Authority icon.png
Issue date: 09/29/2022
From: Jim Barstow
Tennessee Valley Authority
To:
Document Control Desk, Office of Nuclear Reactor Regulation
Shared Package
ML22272A053 List:
References
CNL-22-096, EPID L-2021-LLA-0132
Download: ML22272A054 (23)


Text

Proprietary Information - Withhold Under 10 CFR § 2.390 This letter is decontrolled when separated from Enclosure 1 1101 Market Street, Chattanooga, Tennessee 37402 CNL-22-096 September 29, 2022 10 CFR 50.90 ATTN: Document Control Desk U.S. Nuclear Regulatory Commission Washington, D.C. 20555-0001 Browns Ferry Nuclear Plant, Units 1, 2, and 3 Renewed Facility Operating License Nos. DPR-33, DPR-52, and DPR-68 NRC Docket Nos. 50-259, 50-260, and 50-296

Subject:

Supplement 6 to Request for License Amendment Regarding Application of Advanced Framatome Methodologies, and Adoption of TSTF-564 Revision 2 for Browns Ferry Nuclear Plant Units 1, 2, and 3, in Support of ATRIUM 11 Fuel Use at Browns Ferry (TS-535)

(EPID L-2021-LLA-0132)

Reference:

TVA letter to NRC, CNL-21-053, Request for License Amendment Regarding Application of Advanced Framatome Methodologies, and Adoption of TSTF-564, Revision 2 for Browns Ferry Nuclear Plant Units 1, 2, and 3, in Support of ATRIUM 11 Fuel Use at Browns Ferry (TS-535), dated July 23, 2021 (ML21204A128 and ML21204A129)

In the referenced letter, Tennessee Valley Authority (TVA) submitted a request for a Technical Specification (TS) amendment for the Browns Ferry Nuclear Plant (BFN), Units 1, 2, and 3. The proposed license amendments, in part, revise TS 5.6.5.b, Core Operating Limits Report (COLR), to allow application of Advanced Framatome Methodologies for determining core operating limits in support of loading Framatome fuel type ATRIUMTM 1 11.

In Attachment 4 to the referenced letter, in part, TVA committed to submit the BFN Unit 2 Cycle 23 Safety Limit Analysis Report (i.e., FS1-0060560) to the Nuclear Regulatory Commission, for information only, within 15 days following TVA approval of the report. This report was approved by TVA on September 15, 2022 and is included in Enclosure 1. contains information considered proprietary to Framatome Inc. (Framatome).

As owner of the proprietary information, Framatome has executed an affidavit contained in which identifies the information as proprietary, is customarily held in confidence, and should be withheld from public disclosure in accordance with Title 10 of the Code of Federal Regulations (10 CFR) 2.390. Enclosure 2 provides the non-proprietary version of the Enclosure 1 report. Correspondence with respect to the copyright or proprietary aspects 1 ATRIUM 11 is a trademark or registered trademarks of Framatome, Inc., its affiliates and/or its subsidiaries in the United States of America and may be registered in other countries throughout the world. All rights reserved. Unauthorized use is strictly prohibited. Other names may be trademarks of their respective owners.

Proprietary Information - Withhold Under 10 CFR § 2.390 This letter is decontrolled when separated from Enclosure 1

Proprietary Information - Withhold Under 10 CFR § 2.390 This letter is decontrolled when separated from Enclosure 1 U.S. Nuclear Regulatory Commission CNL-22-096 Page 2 September 29, 2022 of the item listed above or the supporting Framatome affidavit should reference the corresponding report and should be addressed to Alan Meginnis, Framatome, Manager, Product Licensing, 2101 Horn Rapids Road, Richland, WA 99354.

This letter does not change the no significant hazards consideration or the environmental considerations contained in the referenced letter. Additionally, in accordance with 10 CFR 50.91(b)(1), TVA is sending a copy of this letter and the non-proprietary enclosures to the Alabama Department of Public Health.

There are no new regulatory commitments associated with this submittal. Please address any questions regarding this submittal to Stuart L. Rymer, Senior Manager, Fleet Licensing, at slrymer@tva.gov.

I declare under penalty of perjury that the foregoing is true and correct. Executed on this 29th day of September 2022.

Respectfully, Digitally signed by Rearden, Pamela S Date: 2022.09.29 09:43:18 -04'00' James Barstow Vice President, Nuclear Regulatory Affairs & Support Services

Enclosures:

1. FS1-0060560, Browns Ferry Unit 2 Cycle 23 Safety Limit Analysis, Revision 1, Framatome, July 2022 (Proprietary)
2. FS1-0060561, Browns Ferry Unit 2 Cycle 23 Safety Limit Analysis, Revision 1, Framatome, July 2022 (Non-Proprietary)
3. Framatome Affidavit for Enclosure 1 cc: (Enclosures):

NRC Regional Administrator - Region II NRC Project Manager - Browns Ferry Nuclear Plant NRC Senior Resident Inspector - Browns Ferry Nuclear Plant State Health Officer, Alabama Department of Public Health (w/o Enclosure 1)

Proprietary Information - Withhold Under 10 CFR § 2.390 This letter is decontrolled when separated from Enclosure 1

Proprietary Information - Withhold Under 10 CFR § 2.390 Enclosure 1 FS1-0060560, Browns Ferry Unit 2 Cycle 23 Safety Limit Analysis, Revision 1, Framatome, July 2022 (Proprietary)

CNL-22-096 Proprietary Information - Withhold Under 10 CFR § 2.390

Enclosure 2 FS1-0060561, Browns Ferry Unit 2 Cycle 23 Safety Limit Analysis, Revision 1, Framatome, July 2022, (Non-Proprietary)

CNL-22-096

7KLVGRFXPHQWLVHOHFWURQLFDOO\DSSURYHG5HFRUGVUHJDUGLQJWKHVLJQDWXUHVDUHVWRUHGLQWKHIVDQSH[S ('506REMHFW,GGIGI

'RFXPHQWXPGRFEDVH$Q\DWWHPSWWRPRGLI\WKLVILOHPD\VXEMHFWHPSOR\HHVWRFLYLODQGFULPLQDOSHQDOWLHV 5HOHDVHGGDWH :HVWHUQ(8WLPH 

5ROH 1DPH 'DWH <<<<00 2UJDQL]DWLRQ

ULWHU 7289$11$6*HRUJH  )UDPDWRPH,QF
ULWHU 0(//,1*(56HDQ  )UDPDWRPH,QF

5HYLHZHU &52&.(77'HDQ  )UDPDWRPH,QF

5HYLHZHU -2**(567-HII  )UDPDWRPH,QF

$SSURYHU 0(*,11,6$ODQ  )UDPDWRPH,QF

$SSURYHU 6&+1(335REHUW  )UDPDWRPH,QF

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

5(9,6,216

5(9,6,21 '$7( (;3/$1$725<127(6 6HHVW SDJH 1HZGRFXPHQW



UHOHDVHGDWH 7KLVLVWKHQRQSURSULHWDU\YHUVLRQRI)6

6,*1$785(%/2&.

'RFXPHQWDWLRQRI0XOWLSOH$QDO\VWV5HYLHZHUVDQG $SSURYHUV 5ROH 7\SHRI5HYLHZ

 :ULWHU$QDO\VW 7 7HFKQLFDO 5 5HYLHZHU ' 

$ $SSURYHU 3DJHV6HFWLRQV 'RFXPHQWDWLRQ 1DPH / /HDG 3UHSDUHG5HYLHZHG$SSURYHG  % %RWK 6HDQ0HOOLQJHU /: $OO 1$

6HFWLRQQG SDUDJUDSK DQG

  • HRUJH7RXYDQQDV  : 1$

)LJXUHWKURXJK)LJXUH

$OOH[FHSW6HFWLRQQG SDUDJUDSK DQG

'HDQ&URFNHWW /5  %

)LJXUHWKURXJK)LJXUH

6HFWLRQQG SDUDJUDSKDQG

-HII-RJJHUVW 5  %

)LJXUHWKURXJK)LJXUH

5REHUW6FKQHSS $ $OO 1$

$ODQ0HJLQQLV $ $OO 1$

3 3UHSDUHU 5 5HYLHZHU

/ /HDG

$75,80LVD WUDGHPDUNRI)UDPDWRPHRULWVDIILOLDWHV

LQWKH86$RU RWKHUFRXQWULHV

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

7$%/(2)&217(176

 385326( 

 0(7+2'2/2*< 

 $1$/<6,6 

 ',6&866,212)5(68/76 

 5()(5(1&(6 

/,672)7$%/(6 7DEOH)XHODQG3ODQW5HODWHG8QFHUWDLQWLHVIRU6DIHW\/LPLW0&35$QDO\VHV 

7DEOH5HVXOWV6XPPDU\IRU6DIHW\/LPLW0&35$QDO\VHV  

7DEOH&RQWULEXWLRQRI7RWDO3UHGLFWHG5RGVLQ%7E\1XFOHDU)XHO7\SH 

/,672)),*85(6

)LJXUH%URZQV)HUU\8QLW&\FOH(380(///$3RZHU)ORZ0DS  

)LJXUH%URZQV)HUU\8QLW&\FOH&RUH/RDGLQJ0DS  

)LJXUH%URZQV)HUU\8QLW&\FOH5DGLDO3RZHU'LVWULEXWLRQ0DS> @ 

)LJXUH%URZQV)HUU\8QLW&\FOH&KDQQHO)OXHQFH*UDGLHQW'LVWULEXWLRQ 

)LJXUH%URZQV)HUU\8QLW&\FOH5HIHUHQFH)XOO&RUH/RDGLQJ3DWWHUQ 

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

 385326(

$VLQGLFDWHGLQ5HIHUHQFH$WWDFKPHQW$,WHP,,,$%URZQV)HUU\8QLW&\FOH %)( LV

H[SHFWHGWREHDSSURYHGE\WKH8QLWHG6WDWHV1XFOHDU5HJXODWRU\&RPPLVVLRQ 8615& WRDGRSW

767)7KHDSSURYDORI767)DOORZVIRUDF\FOHLQGHSHQGHQWVDIHW\OLPLWWREHSURYLGHGLQWKH

SODQW¶V7HFKQLFDO6SHFLILFDWLRQVWKDWHVWDEOLVKHVDGHVLJQOLPLWEDVHGXSRQWKHFULWLFDOSRZHUFRUUHODWLRQ

DQGLWVXQFHUWDLQW\7KLVOLPLWLVGHWHUPLQHGWREHWKHYDOXHRI&35VXFKWKDWDWWKHFRQILGHQFH OHYHOWKHUHLVDSUREDELOLW\GU\RXWLVDYRLGHG7KLVLVUHIHUUHGWRDV6/0&356/0&35VHWV

WKHIORRUYDOXHRIWKH6/0&35VXSSRUWHGIRUWKHF\FOHVSHFLILFGHYHORSPHQWRIWKHRSHUDWLQJOLPLWV7KH

6/0&35 LV IRU ERWK WKH$75,80DQG$75,80;0IXHOGHVLJQVFRQVLVWHQWZLWK

5HIHUHQFH

KHQWKHUHDFWRULVRSHUDWLQJDWRUDERYHWKHF\FOHVSHFLILFVDIHW\OLPLWDWOHDVWRIWKHURGVLQWKH

FRUHDUHH[SHFWHGWRDYRLGERLOLQJWUDQVLWLRQ7KLVF\FOHVSHFLILF6/0&35LVUHIHUUHGWRDV6/0&35

WKHUHPDLQGHURIWKLVGRFXPHQWZLOOXVH6/0&35ZKHQUHIHUULQJWR6/0&35 7KHSXUSRVHRIWKLV

GRFXPHQW LVWRSURYLGH6/0&35  UHVXOWVIRU%)( LQVXSSRUWRIWKHILUVWF\FOHRI%URZQV)HUU\

RSHUDWLQJXQGHU767) 6/0&35 DQDO\VHV IRUWZRORRSRSHUDWLRQ 7/2 FRYHUWKHHQWLUH

SRZHU IORZPDSDVVKRZQLQ)LJXUH6/0&35 DQDO\VHV IRUVLQJOHORRSRSHUDWLRQ 6/2 FRYHU

RSHUDWLRQEHORZWKHFXUUHQW0(///$XSSHUERXQGDU\

 0(7+2'2/2*<

7KHDQDO\VLVSUHVHQWHGLQWKLVGRFXPHQWXVHGWKHPHWKRGRORJ\SUHVHQWHGLQ5HIHUHQFH7KH6/0&35

LVGHILQHGDVWKHPLQLPXPYDOXHRIWKHFULWLFDOSRZHUUDWLRZKLFKHQVXUHVDWOHDVWRIWKHIXHOURGVLQ

WKHFRUHDUHH[SHFWHGWRDYRLGERLOLQJWUDQVLWLRQGXULQJQRUPDORSHUDWLRQRUDQDQWLFLSDWHGRSHUDWLRQDO

RFFXUUHQFH $22 7KH6/0&35LVGHWHUPLQHGXVLQJDVWDWLVWLFDODQDO\VLVHPSOR\LQJ D0RQWH&DUOR

SURFHVVWKDWSHUWXUEVNH\LQSXWSDUDPHWHUVXVHGLQWKHFDOFXODWLRQRI 0&357KHVHWRIXQFHUWDLQWLHV

XVHGLQWKHVWDWLVWLFDODQDO\VLVLQFOXGHERWKIXHODQGSODQWUHODWHGXQFHUWDLQWLHV

7KH6/0&35DQDO\VLVLVSHUIRUPHGZLWKDSRZHUGLVWULEXWLRQFRQVHUYDWLYHO\UHSUHVHQWLQJ H[SHFWHG

UHDFWRURSHUDWLQJVWDWHVWKDWFRXOGERWKH[LVWDWWKHRSHUDWLQJOLPLW0&35 2/0&35 DQGSURGXFHD

0&35HTXDOWRWKH6/0&35GXULQJDQ$22 >

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

,QWKH)UDPDWRPH PHWKRGRORJ\WKHHIIHFWVRIFKDQQHOERZRQWKHFULWLFDOSRZHUSHUIRUPDQFHDUH

DFFRXQWHGIRULQWKH6/0&35DQDO\VLV5HIHUHQFHGLVFXVVHVWKHDSSOLFDWLRQRIWKH UHDOLVWLFFKDQQHOERZ

PRGHO IRXQGLQ5HIHUHQFH

 $1$/<6,6 7KHILQDOFRUHGHVLJQDQGVWHSWKURXJKGHYHORSHGE\)UDPDWRPH WRPHHWWKHRSHUDWLQJUHTXLUHPHQWV VSHFLILHGE\79$ 5HIHUHQFH ZDVXVHGLQWKH%)( 0&35VDIHW\OLPLWDQDO\VLV7KH%)( FRUH

LVPDGHXSRI$75,80DQG$75,80 ;0 IXHO GHVLJQV7KH%)( GHVLJQVXSSRUWVRSHUDWLRQWR

WKHOLFHQVLQJHQGRIF\FOH (2& H[SRVXUHRIDSSUR[LPDWHO\0:G078 7KHGHVLJQLQFOXGHV

H[WHQVLRQVIRUILQDOIHHGZDWHUWHPSHUDWXUHUHGXFWLRQ ))75 DQGFRDVWGRZQ)LJXUHSUHVHQWVWKHFRUH

ORDGLQJWKHF\FOHWKHIXHOZDVRULJLQDOO\ORDGHGDQGWKH QXPEHURIDVVHPEOLHV$QDO\VHVZHUHSHUIRUPHG

@ IRUWKH%URZQV)HUU\SRZHUIORZPDSIRU0(///$

RSHUDWLRQDVVKRZQLQ)LJXUH)RUWKH> @ VWDWH SRLQWWKH7/2FRUHIORZXQFHUWDLQW\

JLYHQLQ7DEOHZDVXVHG)RUWKH> @ DWIXOOSRZHUDQG> @ VWDWH SRLQWV

WKH6/2FRUHIORZXQFHUWDLQW\LQ7DEOHZDVXVHGFRQVLVWHQWZLWKWKHUHVWULFWLRQVOLVWHGLQ6HFWLRQ

RIWKH5HIHUHQFH6DIHW\(YDOXDWLRQ5HSRUW7KHUDGLDOSRZHUGLVWULEXWLRQ>

@ LVSUHVHQWHGLQ )LJXUH

7KHFDOFXODWHGIDVWIOXHQFHJUDGLHQWVIRUWKH%)( FRUHGHVLJQKDYHEHHQFRPSDUHGWRWKHXSSHUDQG

ORZHUERXQGVRIWKHFKDQQHOERZGDWDEDVH$VVKRZQLQ)LJXUHWKHUHDUH>

@ WKH XSSHUORZHUERXQGRIWKHFKDQQHOERZGDWDEDVH 7KHFKDQQHOERZPRGHOXQFHUWDLQW\

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

IRUWKHDVVHPEOLHVH[SHULHQFLQJ IOXHQFHJUDGLHQWVRXWVLGHWKHERXQGVRIWKHPHDVXUHPHQWGDWDEDVHZDV

DXJPHQWHGZLWKWKHVDPHDSSURDFKDVGHPRQVWUDWHGLQWKH5HVSRQVHWR613%5$,LQ5HIHUHQFH

7KH$&($75,80FULWLFDOSRZHUFRUUHODWLRQ 5HIHUHQFH LVXVHGIRUWKH$75,80IXHODVVHPEOLHV

DQGWKH $&($75,80;0FULWLFDOSRZHUFRUUHODWLRQ 5HIHUHQFH LVXVHGIRUWKH$75,80;0IXHO DVVHPEOLHV7KHIXHODQGSODQWUHODWHGXQFHUWDLQWLHVXVHGLQWKH%)( 6/0&35DQDO\VLVDUH

SUHVHQWHGLQ7DEOH7KHUDGLDODQG QRGDOSRZHUXQFHUWDLQWLHV XVHGLQWKHDQDO\VLVLQFOXGHWKHHIIHFWVRI

XSWR RIWKHORFDOSRZHUUDQJHPRQLWRUV /350 RXWRIVHUYLFHXSWR WUDYHOLQJLQFRUHSUREH 7,3 

FKDQQHOV RXWRIVHUYLFHDQGDHIIHFWLYHIXOOSRZHUKRXU ()3+ /350FDOLEUDWLRQLQWHUYDO

%RWKWKH$&($75,80 5HIHUHQFH DQGWKH$&($75,80;0 5HIHUHQFH FULWLFDOSRZHU

FRUUHODWLRQVKDYHDQ6(5UHVWULFWLRQOLPLWLQJ WKHORFDOSHDNLQJIDFWRUWR > @ )XHOH[SHFWHGWREH

UHVLGHQWLQ%)( KDVEHHQGHVLJQHGWREHEHORZWKLVOLPLW7KHPD[LPXPORFDOSHDNLQJ IDFWRUIRUWKH

IUHVK$75,80 ODWWLFHLV> @ 'XULQJHDFK0RQWH&DUORWULDORIWKH6/0&35FDOFXODWLRQ >

@ 7KHEDVHDGGLWLYHFRQVWDQWXQFHUWDLQW\

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

DQGWKHKLJKSLQSRZHUDGGLWLYHFRQVWDQWXQFHUWDLQW\YDOXHVDUHSUHVHQWHGLQ7DEOHRIWKH6$)/,0'

WRSLFDOUHSRUW 5HIHUHQFH 

7KH%)( 6/0&35DQDO\VLVVXSSRUWVD7/26/0&35RIDQGDQ6/26/0&35RI)RU

RSHUDWLRQZLWKLQWKH0(///$RSHUDWLQJGRPDLQ6/2LVQRWDOORZHG7DEOHSUHVHQWVDVXPPDU\RIWKH

DQDO\VLVUHVXOWVLQFOXGLQJWKH6/0&35DQGWKH SHUFHQWDJHRIURGV H[SHFWHGWRH[SHULHQFHERLOLQJ

WUDQVLWLRQ7KHSHUFHQWDJHVRIWKHWRWDOQXPEHURIIXHOURGVSUHGLFWHGWRH[SHULHQFHERLOLQJWUDQVLWLRQLQWKH

RYHUDOO0RQWH&DUORVWDWLVWLFDOHYDOXDWLRQDVVRFLDWHGZLWKHDFKQXFOHDUIXHOW\SHDUHSUHVHQWHGLQ7DEOH

7KHUHVXOWVDUHIRUWKH>

 ',6&866,212)5(68/76

$QDO\VLVUHVXOWVVXSSRUWD7/26/0&35RIDQGD6/26/0&35RI$QDO\VLVUHVXOWVLQFOXGLQJ

WKH6/0&35DQGWKHSHUFHQWDJHRIURGVH[SHFWHGWRH[SHULHQFHERLOLQJWUDQVLWLRQDUHVXPPDUL]HGLQ

7DEOH

 5()(5(1&(6

 )65HYLVLRQ³%URZQV)HUU\8QLW&\FOH&DOFXODWLRQ3ODQ')UDPDWRPH,QF

0DUFK

 $1335HYLVLRQ³'HVLJQ/LPLWVIRU)UDPDWRPH&ULWLFDO3RZHU&RUUHODWLRQV'

)UDPDWRPH,QF-XO\

 $133$5HYLVLRQ³$5(9$0&356DIHW\/LPLW0HWKRGRORJ\IRU%RLOLQJ:DWHU5HDFWRUV'

$5(9$13,QF-XQH

  %$:3$5HYLVLRQ³5HDOLVWLF7KHUPDO0HFKDQLFDO)XHO5RG0HWKRGRORJ\IRU%RLOLQJ

DWHU5HDFWRUV'$5(9$13,QF)HEUXDU\

 $1335HYLVLRQ³%URZQV)HUU\8QLW&\FOH)XHO&\FOH'HVLJQ5HSRUW'

)UDPDWRPH,QF$SULO

 1('2$5HYLVLRQ³*HQHUDO(OHFWULF%RLOLQJ:DWHU5HDFWRU0D[LPXP([WHQGHG/RDG

/LQH/LPLW$QDO\VLV3OXV'2FWREHU

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

 $1335HYLVLRQ³$5(9$5$,5HVSRQVHVIRU%URZQV)HUU\$75,80;0)XHO

7UDQVLWLRQ'$5(9$13,QF6HSWHPEHU

 $133$5HYLVLRQ³$&($75,80&ULWLFDO3RZHU&RUUHODWLRQ')UDPDWRPH,QF

0D\

 $133$5HYLVLRQ³$&($75,80;0&ULWLFDO3RZHU&RUUHODWLRQ'$5(9$,QF

0DUFK

 /HWWHU+'RQDOG&XUHW $5(9$ WR+-5LFKLQJV 8615& ³32:(53/(;£ &RUH0RQLWRULQJ

)DLOHGRU%\SDVVHG,QVWUXPHQWDWLRQDQG([WHQGHG&DOLEUDWLRQ'+'&0D\ 

 

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

7DEOH)XHODQG3ODQW5HODWHG8QFHUWDLQWLHVIRU 6DIHW\/LPLW0&35$QDO\VHV 6WDQGDUG

3DUDPHWHU 'HYLDWLRQ Fuel-Related Uncertainties











Plant-Related Uncertainties

)HHGZDWHUIORZUDWH 

)HHGZDWHUWHPSHUDWXUH 

&RUHSUHVVXUH 

7RWDOFRUHIORZUDWH

7/2 

6/2 

 > @

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

7DEOH5HVXOWV6XPPDU\IRU 6DIHW\/LPLW0&35$QDO\VHV 3HUFHQWDJHRI

5RGVLQ%RLOLQJ

3RZHU)ORZ 6/0&35 7UDQVLWLRQ

> @ 7/2 

> @ 7/2 

> @ 7/2 

> @ 6/2 

7DEOH&RQWULEXWLRQRI7RWDO3UHGLFWHG5RGV LQ%7E\1XFOHDU)XHO7\SH

&RQWULEXWLRQRI7RWDO5RGV 3UHGLFWHGWREHLQ%7 

1XFOHDU

)XHO )XHO %XUQXS 7/2 6/2 7\SH 'HVLJQ 6WDWXV  

 $75,80;0 7ZLFH%XUQHG 

 $75,80;0 7ZLFH%XUQHG 

 $75,80;0 7ZLFH%XUQHG 

 $75,80;0 2QFHEXUQHG 

 $75,80;0 2QFHEXUQHG 

 $75,80 )UHVK 

 $75,80 )UHVK 

 $75,80 )UHVK 

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

)LJXUH%URZQV)HUU\8QLW&\FOH (380(///$3RZHU)ORZ0DS

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

23 21 22 22 21 23 23 23 23 21 22 22 23 21 21 23 23 25 25 25 25 25 25 25 25 25 25 23 21 22 22 22 23 24 28 25 28 28 28 25 25 28 28 28 25 28 24 23 21 21 23 25 24 28 28 26 28 24 26 26 26 26 24 28 26 28 28 24 25 22 21 21 28 28 28 26 25 26 25 26 24 24 26 25 26 25 26 28 28 28 23 22 21 22 21 25 28 24 26 24 26 24 27 24 27 27 24 27 24 26 24 26 24 28 25 23 23 21 21 25 28 28 26 26 24 26 24 27 24 27 24 24 27 24 27 24 26 24 26 26 28 28 25 21 21 23 24 28 24 26 24 27 24 27 24 27 24 27 27 24 27 24 27 24 27 24 26 24 28 24 23 22 23 23 24 28 28 26 24 27 24 27 24 27 25 27 24 24 27 25 27 24 27 24 27 24 26 28 28 24 23 21 23 23 28 28 26 24 26 24 27 24 27 24 27 24 27 27 24 27 24 27 24 27 24 26 24 26 28 28 23 22 22 25 25 26 25 26 24 27 24 27 24 27 24 27 24 24 27 24 27 24 27 24 27 24 26 25 26 25 25 21 22 25 28 28 26 24 27 24 27 24 27 24 27 24 27 27 24 27 24 27 24 27 24 27 24 26 28 28 25 22 21 25 28 24 25 27 24 27 25 27 24 27 24 27 24 24 27 24 27 24 27 25 27 24 27 25 24 28 25 23 23 25 28 26 26 24 27 24 27 24 27 24 27 24 27 27 24 27 24 27 24 27 24 27 24 26 26 28 25 23 23 25 25 26 24 27 24 27 24 27 24 27 24 27 24 24 27 24 27 24 27 24 27 24 27 24 26 25 25 23 23 25 25 26 24 27 24 27 24 27 24 27 24 27 24 24 27 24 27 24 27 24 27 24 27 24 26 25 25 23 23 25 28 26 26 24 27 24 27 24 27 24 27 24 27 27 24 27 24 27 24 27 24 27 24 26 26 28 25 23 21 25 28 24 25 27 24 27 25 27 24 27 24 27 24 24 27 24 27 24 27 25 27 24 27 25 24 28 25 21 22 25 28 28 26 24 27 24 27 24 27 24 27 24 27 27 24 27 24 27 24 27 24 27 24 26 28 28 25 22 22 25 25 26 25 26 24 27 24 27 24 27 24 27 24 24 27 24 27 24 27 24 27 24 26 25 26 25 25 22 21 23 28 28 26 24 26 24 27 24 27 24 27 24 27 27 24 27 24 27 24 27 24 26 24 26 28 28 23 21 23 23 24 28 28 26 24 27 24 27 24 27 25 27 24 24 27 25 27 24 27 24 27 24 26 28 28 24 23 21 22 23 24 28 24 26 24 27 24 27 24 27 24 27 27 24 27 24 27 24 27 24 26 24 28 24 23 21 22 25 28 28 26 26 24 26 24 27 24 27 24 24 27 24 27 24 26 24 26 26 28 28 25 23 21 23 21 25 28 24 26 24 26 24 27 24 27 27 24 27 24 26 24 26 24 28 25 21 21 22 21 21 28 28 28 26 25 26 25 26 24 24 26 25 26 25 26 28 28 28 23 22 22 25 24 28 28 26 28 24 26 26 26 26 24 28 26 28 28 24 25 23 22 23 23 24 28 25 28 28 28 25 25 28 28 28 25 28 24 23 21 22 21 23 23 25 25 25 25 25 25 25 25 25 25 23 23 22 23 21 22 23 21 22 23 23 23 21 22 22 23 21 1XFOHDU )XHO &\FOH 1XPEHURI

)XHO7\SH 'HVFULSWLRQ /RDGHG $VVHPEOLHV

 $75,80;0  

 $75,80;0  

 $75,80;0  

 $75,80;0  

 $75,80;0  

 $75,80  

 $75,80  

 $75,80  

)LJXUH%URZQV)HUU\8QLW&\FOH &RUH/RDGLQJ0DS

1)6 5HY

%URZQV)HUU\8QLW&\FOH6DIHW\

/LPLW$QDO\VLV

+DQGOLQJ121( 3DJH 1RQ3URSULHWDU\

0.255 0.307 0.348 0.379 0.401 0.415 0.413 0.316 0.472 0.578 0.726 0.766 0.784 0.783 0.775 0.237 0.379 0.557 0.791 1.053 0.943 1.151 1.170 1.174 0.986 0.406 0.707 0.862 1.159 1.239 1.253 1.294 1.084 1.276 1.279 0.397 0.603 1.055 1.201 1.289 1.309 1.150 1.325 1.149 1.339 1.162 0.236 0.394 0.606 0.896 1.209 1.109 1.322 1.151 1.348 1.158 1.349 1.152 1.357 0.393 0.712 1.064 1.217 1.279 1.328 1.147 1.352 1.176 1.349 1.137 1.314 1.110 0.322 0.576 0.869 1.212 1.116 1.331 1.165 1.353 1.160 1.353 1.127 1.259 1.060 1.242 0.271 0.468 0.798 1.166 1.296 1.329 1.155 1.355 1.177 1.357 1.151 1.266 0.866 0.976 0.999 0.319 0.580 1.057 1.243 1.313 1.155 1.355 1.167 1.354 1.144 1.307 1.052 0.969 0.818 1.133 0.354 0.726 0.944 1.254 1.150 1.351 1.176 1.350 1.130 1.292 1.074 1.199 0.971 1.116 0.976 0.379 0.763 1.150 1.293 1.327 1.161 1.352 1.128 1.251 1.039 1.194 0.991 1.111 0.938 1.130 0.395 0.780 1.165 1.085 1.149 1.352 1.140 1.270 0.865 0.965 0.964 1.108 0.778 0.896 0.938 0.412 0.774 1.166 1.269 1.333 1.149 1.326 1.070 0.978 0.817 1.112 0.932 0.893 0.766 1.081 0.395 0.766 0.975 1.267 1.149 1.341 1.111 1.246 1.002 1.132 0.975 1.122 0.917 1.071 0.925 0.405 0.768 0.976 1.268 1.141 1.342 1.111 1.246 1.001 1.131 0.974 1.121 0.915 1.069 0.922 0.415 0.778 1.168 1.270 1.333 1.152 1.327 1.067 0.975 0.816 1.112 0.930 0.883 0.751 1.078 0.397 0.782 1.167 1.089 1.150 1.353 1.146 1.271 0.864 0.964 0.977 1.107 0.765 0.886 0.934 0.379 0.765 1.151 1.295 1.328 1.163 1.354 1.134 1.251 1.039 1.196 0.996 1.110 0.936 1.129 0.351 0.728 0.945 1.255 1.151 1.353 1.178 1.351 1.130 1.294 1.074 1.201 0.973 1.118 0.979 0.312 0.585 1.057 1.243 1.315 1.156 1.356 1.168 1.356 1.151 1.310 1.054 0.971 0.821 1.134 0.261 0.484 0.789 1.166 1.297 1.330 1.153 1.357 1.178 1.360 1.155 1.269 0.868 0.977 1.000 0.328 0.564 0.870 1.214 1.118 1.333 1.174 1.356 1.161 1.356 1.129 1.260 1.057 1.241 0.378 0.713 1.066 1.219 1.280 1.329 1.150 1.353 1.179 1.351 1.138 1.314 1.110 0.233 0.409 0.610 0.898 1.210 1.103 1.322 1.152 1.349 1.151 1.349 1.152 1.357 0.400 0.606 1.056 1.201 1.289 1.309 1.151 1.326 1.150 1.339 1.162 0.389 0.710 0.867 1.161 1.240 1.253 1.294 1.088 1.277 1.279 0.237 0.401 0.564 0.794 1.056 0.944 1.152 1.170 1.174 0.987 0.326 0.482 0.586 0.731 0.770 0.785 0.784 0.776 0.262 0.311 0.355 0.388 0.401 0.398 0.416 0.415 0.421 0.402 0.382 0.351 0.304 0.246 0.776 0.785 0.786 0.766 0.725 0.559 0.453 0.319 0.986 1.174 1.169 1.149 0.939 1.047 0.787 0.577 0.391 0.236 1.279 1.276 1.084 1.291 1.249 1.234 1.157 0.864 0.712 0.395 1.161 1.338 1.148 1.322 1.140 1.304 1.285 1.198 1.058 0.641 0.411 1.357 1.150 1.347 1.147 1.344 1.148 1.317 1.094 1.210 0.903 0.628 0.417 0.241 1.110 1.314 1.136 1.347 1.174 1.348 1.142 1.324 1.279 1.221 1.071 0.718 0.396 1.243 1.057 1.259 1.126 1.351 1.157 1.351 1.164 1.331 1.119 1.216 0.872 0.578 0.329 1.012 0.980 0.874 1.268 1.152 1.357 1.175 1.355 1.161 1.330 1.298 1.167 0.790 0.467 0.235 1.135 0.822 0.972 1.053 1.309 1.150 1.354 1.167 1.356 1.155 1.314 1.243 1.056 0.578 0.301 0.976 1.119 0.974 1.202 1.073 1.294 1.133 1.351 1.178 1.352 1.150 1.255 0.944 0.728 0.356 1.130 0.938 1.112 0.998 1.197 1.041 1.251 1.134 1.353 1.153 1.326 1.294 1.152 0.768 0.383 0.934 0.896 0.778 1.110 0.979 0.965 0.863 1.270 1.139 1.351 1.147 1.088 1.169 0.784 0.414 1.081 0.766 0.893 0.933 1.114 0.818 0.975 1.066 1.326 1.151 1.333 1.270 1.170 0.781 0.421 0.924 1.072 0.919 1.123 0.976 1.132 1.002 1.246 1.111 1.341 1.140 1.269 0.977 0.772 0.410 0.924 1.072 0.917 1.122 0.975 1.132 1.001 1.247 1.112 1.342 1.150 1.269 0.977 0.772 0.422 1.079 0.762 0.892 0.931 1.112 0.811 0.977 1.070 1.328 1.150 1.334 1.270 1.169 0.780 0.423 0.935 0.895 0.777 1.108 0.963 0.965 0.865 1.272 1.146 1.354 1.149 1.086 1.168 0.782 0.401 1.130 0.937 1.111 0.994 1.196 1.040 1.252 1.135 1.355 1.163 1.328 1.294 1.150 0.766 0.379 0.979 1.117 0.972 1.201 1.076 1.293 1.129 1.351 1.178 1.353 1.151 1.254 0.943 0.726 0.342 1.133 0.818 0.968 1.052 1.308 1.150 1.355 1.167 1.356 1.155 1.314 1.242 1.054 0.580 0.307 0.998 0.975 0.866 1.266 1.151 1.358 1.177 1.356 1.155 1.330 1.296 1.164 0.787 0.472 0.252 1.241 1.059 1.258 1.126 1.353 1.158 1.354 1.165 1.332 1.118 1.213 0.869 0.562 0.320 1.110 1.313 1.137 1.348 1.176 1.352 1.147 1.328 1.280 1.219 1.065 0.713 0.402 1.357 1.151 1.348 1.150 1.347 1.152 1.323 1.111 1.211 0.898 0.609 0.398 0.242 1.161 1.339 1.149 1.324 1.149 1.309 1.289 1.202 1.058 0.615 0.391 1.279 1.276 1.084 1.293 1.252 1.238 1.159 0.864 0.710 0.407 0.987 1.174 1.170 1.151 0.943 1.052 0.786 0.557 0.379 0.236 0.776 0.785 0.785 0.768 0.730 0.585 0.456 0.324 0.413 0.419 0.399 0.382 0.352 0.328 0.252

)LJXUH%URZQV)HUU\8QLW&\FOH 5DGLDO3RZHU'LVWULEXWLRQ0DS

> @

Enclosure 3 Framatome Affidavit for Enclosure 1 CNL-22-096

AFFIDAVIT

1. My name is Alan B. Meginnis. I am Manager, Product Licensing, for Framatome Inc. and as such I am authorized to execute this Affidavit.
2. I am familiar with the criteria applied by Framatome to determine whether certain Framatome information is proprietary. I am familiar with the policies established by Framatome to ensure the proper application of these criteria.
3. I am familiar with the Framatome information contained in the report FS1-0060560, Revision 1, Browns Ferry Unit 2 Cycle 23 Safety Limit Analysis, dated July, 2022 and referred to herein as Document. Information contained in this Document has been classified by Framatome as proprietary in accordance with the policies established by Framatome for the control and protection of proprietary and confidential information.
4. This Document contains information of a proprietary and confidential nature and is of the type customarily held in confidence by Framatome and not made available to the public. Based on my experience, I am aware that other companies regard information of the kind contained in this Document as proprietary and confidential.
5. This Document has been made available to the U.S. Nuclear Regulatory Commission in confidence with the request that the information contained in this Document be withheld from public disclosure. The request for withholding of proprietary information is made in accordance with 10 CFR 2.390. The information for which withholding from disclosure is requested qualifies under 10 CFR 2.390(a)(4) Trade secrets and commercial or financial information.
6. The following criteria are customarily applied by Framatome to determine whether information should be classified as proprietary:

(a) The information reveals details of Framatomes research and development plans and programs or their results.

(b) Use of the information by a competitor would permit the competitor to significantly reduce its expenditures, in time or resources, to design, produce, or market a similar product or service.

(c) The information includes test data or analytical techniques concerning a process, methodology, or component, the application of which results in a competitive advantage for Framatome.

(d) The information reveals certain distinguishing aspects of a process, methodology, or component, the exclusive use of which provides a competitive advantage for Framatome in product optimization or marketability.

(e) The information is vital to a competitive advantage held by Framatome, would be helpful to competitors to Framatome, and would likely cause substantial harm to the competitive position of Framatome.

The information in the Document is considered proprietary for the reasons set forth in paragraphs 6(b), 6(d) and 6(e) above.

7. In accordance with Framatomes policies governing the protection and control of information, proprietary information contained in this Document have been made available, on a limited basis, to others outside Framatome only as required and under suitable agreement providing for nondisclosure and limited use of the information.
8. Framatome policy requires that proprietary information be kept in a secured file or area and distributed on a need-to-know basis.
9. The foregoing statements are true and correct to the best of my knowledge, information, and belief.

I declare under penalty of perjury that the foregoing is true and correct.

Executed on: July 25, 2022 MEGINNIS Alan Digitally signed by MEGINNIS Alan Date: 2022.07.25 09:17:42 -07'00' Alan B. Meginnis